GNH USA

Europe — EMA

Leuprorelin Sandoz

GNH USA supplies Leuprorelin Sandoz (Leuprorelin), a GnRH agonist for prostate cancer, endometriosis, uterine fibroids, precocious puberty and breast cancer

Leuprorelin

Request sourcing

1
Pack/s

What is Leuprorelin?

Leuprorelin, the active ingredient in Leuprorelin Sandoz, is a Gonadotropin‑releasing hormone (GnRH) agonist presented as a sterile solution for subcutaneous use. It suppresses sex‑hormone production and is employed in the management of hormone‑sensitive cancers and benign gynecological conditions in adults and adolescents.

GNH USA supplies Leuprorelin Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

What is Leuprorelin used for?

Leuprorelin acts on the GnRH pathway to control hormone‑driven diseases. - Prostate cancer: lowers testosterone to inhibit tumor growth. - Endometriosis: reduces estrogen levels to alleviate pelvic pain and lesions. - Uterine fibroids: suppresses estradiol to shrink fibroid size and improve symptoms. - Precocious puberty: halts premature sexual development by blocking gonadotropin release. - Breast cancer (adjuvant therapy): diminishes estrogen exposure to support hormonal treatment.

What are the side effects of Leuprorelin?

Leuprorelin may cause a range of adverse reactions.

Common Side Effects: - Hot flashes - Injection site pain or erythema - Headache - Fatigue

Serious or Rare Side Effects: - Cardiovascular events such as myocardial infarction - Severe allergic reaction (anaphylaxis) - Bone loss leading to fractures - Severe depression or suicidal thoughts

What precautions apply to Leuprorelin?

Before initiating therapy, clinicians should consider several safety measures. - Hormone monitoring: regularly assess testosterone or estradiol levels. - Cardiovascular assessment: evaluate risk factors for heart disease. - Bone health: perform baseline bone density testing and consider supplementation. - Pregnancy contraindication: avoid use in pregnant or potentially pregnant patients. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Leuprorelin interact with?

Leuprorelin can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Androgen receptor antagonists: may diminish therapeutic effect. - Estrogen replacement therapy: can counteract hormone suppression. - Strong CYP3A4 inhibitors: may increase leuprorelin exposure.

Moderate Interactions (Monitor Closely): - Anticoagulants: monitor INR or clotting parameters. - Glucocorticoids: watch for additive bone‑loss risk. - Diuretics: observe electrolyte balance, especially potassium.

Frequently asked questions

What conditions is Leuprorelin Sandoz used to treat?+
Leuprorelin Sandoz is prescribed for hormone‑sensitive conditions such as prostate cancer, endometriosis, uterine fibroids, precocious puberty, and as an adjuvant therapy in certain breast cancers. By suppressing sex‑hormone production, it helps control disease progression and symptom severity in these indications.
How does leuprorelin work in the body?+
Leuprorelin mimics natural GnRH but remains bound to pituitary receptors longer, causing an initial surge followed by down‑regulation of LH and FSH release. The sustained suppression of these gonadotropins leads to markedly lower testosterone and estradiol levels, which reduces hormone‑driven tumor growth and other estrogen‑dependent conditions.
What is the usual dose of Leuprorelin Sandoz?+
The dose of Leuprorelin Sandoz is individualized by the prescribing clinician based on the specific indication, patient weight, and treatment goals. Healthcare professionals determine the appropriate strength, frequency, and duration, and patients should follow the prescriber’s exact instructions.
Is Leuprorelin safe during pregnancy or breastfeeding?+
Leuprorelin is classified as Pregnancy Category X, indicating it is contraindicated in pregnancy because it can cause fetal harm. It is also not recommended while breastfeeding, as it may affect the infant’s hormonal balance. Women of childbearing potential should use effective contraception during treatment.
How do I order Leuprorelin Sandoz from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain logistics if needed), and the necessary import documentation.
How does Leuprorelin compare with other GnRH agonists?+
Leuprorelin belongs to the same class as goserelin and triptorelin, sharing the mechanism of pituitary down‑regulation. Differences lie mainly in formulation, dosing intervals, and manufacturer pricing. Clinical efficacy is comparable, but individual patient tolerance, convenience of injection schedule, and supply chain considerations may influence the choice of agent.
What are the storage and handling requirements for Leuprorelin Sandoz?+
Leuprorelin Sandoz must be stored refrigerated at 2‑8 °C. Keep the vial in its original packaging, protect it from light, and avoid freezing or shaking. If temporary temperature excursions occur, discard the product to ensure potency and safety.
How is Leuprorelin Sandoz administered?+
Leuprorelin Sandoz is given by subcutaneous injection, typically into the abdomen or thigh. The injection is performed by a qualified healthcare professional using aseptic technique. The exact injection site, volume, and frequency are determined by the prescriber according to the therapeutic indication.
What are the most serious risks associated with Leuprorelin therapy?+
Serious risks include cardiovascular events such as myocardial infarction, severe allergic reactions (anaphylaxis), significant bone loss leading to fractures, and profound depression or suicidal ideation. Patients should be monitored closely for these events, and any concerning symptoms should prompt immediate medical evaluation.
Who should not use Leuprorelin Sandoz?+
Leuprorelin is contraindicated in pregnant women, individuals with known hypersensitivity to leuprorelin or any excipients, and patients with severe uncontrolled cardiovascular disease. Caution is also advised for those with existing osteoporosis, severe depression, or active liver disease, and the drug should be avoided in these populations unless benefits clearly outweigh risks.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Leuprorelin
Route
Subcutaneous Use
Manufacturer
Sandoz A/S
Origin
EU

Related products

Camcevi

Camcevi

Leuprorelin

Accord Healthcare S.L.U.
EU
Camcevi

Camcevi

Leuprorelin

Accord Healthcare S.L.U.
EU
Camcevi

Camcevi

Leuprorelin

Accord Healthcare S.L.U.
EU
Camcevi

Camcevi

Leuprorelin

Accord Healthcare S.L.U.
EU